EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Congenital Thrombocytosis, Hepatosplenomegaly, and Rash in a Term Neonate

Michal Mia Shalamov iD, Akshara Vadyala, Nirzar Parikh, Jessica Scerbo, Estephanie Rivero

American Journal of Perinatology Reports · 01.04.2026 · 16 (02) · e101-e104

DOI: 10.1055/a-2851-8535 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Perinatology Reports, erschienen am 01.04.2026. Verfasst von Michal Mia Shalamov und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, HMH K. Hovnanian Children's Hospital at Jersey Shore University Medical Center, Neptune City, NJ, United States. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Transient abnormal myelopoiesis (TAM) is a self-limited clonal myeloproliferative disorder seen almost exclusively in neonates with trisomy 21 and defined by circulating myeloblasts carrying N-terminal truncating GATA1 mutations. Although most cases occur in infants with typical Down syndrome features, TAM can arise in clinically normal newborns with mosaic trisomy 21, creating significant diagnostic uncertainty. Study Design We report a term female neonate who presented with pallor, respiratory distress, hepatosplenomegaly, and a papular, nonblanching rash.

Results

Laboratory studies showed marked thrombocytosis, leukocytosis, and numerous circulating blasts. Flow cytometry detected a 17% abnormal blast population resembling congenital acute myeloid leukemia, but bone marrow aspirate revealed a myeloproliferative picture without definitive malignancy, favoring TAM. Molecular testing confirmed a truncating GATA1 mutation and mosaic trisomy 21 by SNP array, fluorescence in situ hybridization, and microarray. The infant’s condition improved rapidly, with resolution of organomegaly and normalization of blood counts in the first week of life.

Conclusion

This case underscores the diagnostic challenges of TAM in phenotypically normal infants. Because clinical and laboratory findings can closely mimic congenital leukemia, early evaluation for GATA1 mutations and trisomy 21 is essential to establish the correct diagnosis, guide management, and avoid unnecessary chemotherapy.

Schlagwörter

Stichwörter der Autor:innen

GATA1blast cellshepatosplenomegalymosaic Down syndromethrombocytosistransient abnormal myelopoiesis

Autor:innen und Institutionen

  • Department of Pediatrics, HMH K. Hovnanian Children's Hospital at Jersey Shore University Medical Center, Neptune City, NJ, United States.
  • Department of Pediatrics, Division of Neonatology, HMH K. Hovnanian Children's Hospital at Jersey Shore University Medical Center, Neptune City, NJ, United States.
  • Department of Pediatrics, Division of Hematology/Oncology, HMH K. Hovnanian Children's Hospital at Jersey Shore University Medical Center, Neptune City, NJ, United States.

ORCID-Profile: Michal Mia Shalamov

Zitieren

APA

Shalamov, M. M., Vadyala, A., Parikh, N., Scerbo, J., & Rivero, E. (2026). Congenital Thrombocytosis, Hepatosplenomegaly, and Rash in a Term Neonate. American Journal of Perinatology Reports, 16(02), e101-e104. https://doi.org/10.1055/a-2851-8535

Vancouver

Shalamov MM, Vadyala A, Parikh N, Scerbo J, Rivero E. Congenital Thrombocytosis, Hepatosplenomegaly, and Rash in a Term Neonate. American Journal of Perinatology Reports. 2026;16(02):e101-e104. doi:10.1055/a-2851-8535

BibTeX
@article{Shalamov2026,
  author = {Shalamov, Michal Mia and Vadyala, Akshara and Parikh, Nirzar and Scerbo, Jessica and Rivero, Estephanie},
  title = {Congenital Thrombocytosis, Hepatosplenomegaly, and Rash in a Term Neonate},
  journal = {American Journal of Perinatology Reports},
  year = {2026},
  volume = {16},
  number = {02},
  pages = {e101--e104},
  doi = {10.1055/a-2851-8535}
}
Kostenlos starten →